Fidson Healthcare Reports N14.96bn Profit, Declares N3.6bn Dividend

Fidson Healthcare Plc announced a pre-tax profit of N14.96 billion for the financial year ending December 31, 2025, representing a significant 94% increase from N7.7 billion recorded in 2024, according to the company's audited financial statement. The company proposed a total dividend of N3.6 billion for the year, which translates to N1.50 per share, reflecting a 50% increase from the N2.29 billion or N1.00 per share declared in 2024.

Fidson's performance was driven by strong demand across its pharmaceutical portfolio, with revenue rising by 41% to N119.06 billion. However, the cost of sales increased sharply by 42% to N69.84 billion, and administrative expenses expanded to N12.4 billion.

Despite these challenges, Fidson's financial income grew by 140% to N144 million, providing a modest offset to rising financial costs. The company recorded improvements in its balance sheet, asset growth, and reduced leverage, strengthening its financial position and enabling reinvestment for long-term growth.